903
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Inhaled corticosteroids as rescue medication in asthma exacerbations in children

Pages 695-702 | Published online: 10 Jan 2014

References

  • Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J.31(1), 43–178, (2008)
  • Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma – summary report 2007. Allergy Clin. Immunol.120(5 Suppl.), S94–S138 (2007).
  • Bacharier LB, Boner A, Carlsen KH et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy63(5), 34 (2008).
  • Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest130, 1301–1311 (2006).
  • Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir. Med.101, 685–695 (2007).
  • Volovitz B, Nussinovitch M. Management of children with severe asthma exacerbation in the emergency department. Paediatr. Drugs4, 141–148 (2002).
  • Rachelefsky G. Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics112, 382–397 (2003).
  • Volovitz B, Bentur L, Finkelstein Y et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J. Allergy Clin. Immunol.102, 605–609 (1998).
  • Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf.29, 599–612 (2006).
  • Barnes PJ. Inhaled glucocorticoids for asthma. N. Engl. J. Med.332, 868–875 (1995).
  • Volovitz B, Kauschansky A, Nussinovitch M, Harel L, Varsano I. Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide. J. Allergy Clin. Immunol.96, 874–878 (1995).
  • Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I. Growth and pituitary–adrenal function in children with severe asthma treated with inhaled budesonide. N. Engl. J. Med.329, 1703–1708 (1993).
  • De Benedictis FM, Del Giudice MM, Vetrella M et al. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. J. Asthma42, 331–336 (2005).
  • Lin RY, Newman TG, Sauter D et al. Association between reported use of inhaled triamcinolone and differential short-term responses to aerosolized albuterol in asthmatics in an emergency department setting. Chest106, 452–457 (1994).
  • Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur. Respir. J.27, 172–187 (2006).
  • Wanner A, Horvath G, Brieva JL, Kumar SD, Mendes ES. Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma. Proc. Am. Thorac. Soc.1, 235–238 (2004).
  • Urbach V, Walsh DE, Mainprice B, Bousquet J, Harvey BJ. Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J. Physiol.545, 869–878 (2002).
  • Kelly L, Kolbe J, Mitzner W, Spannhake EW, Bromberger-Barnea B, Menkes H. Bronchial blood flow affects recovery from constriction in dog lung periphery. J. Appl. Physiol.60, 1954–1959 (1986).
  • Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch. Dis. Child.68, 85–87 (1993).
  • Svedmyr J, Nyberg E, Asbrink-Nilsson E, Hedlin G. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Paediatr.84, 884–888 (1995).
  • Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch. Dis. Child.65, 407–410 (1990).
  • Volovitz B, Bilavsky E, Nussinovitch M. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. J. Asthma45(7), 561–567 (2008).
  • Mannan SE, Yousef E, Mcgeady SJ. Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations and improved outcomes: a randomized controlled trial. J. Allergy Clin. Immunol.121(Suppl. 1), S219 (2008).
  • Nuhoglu Y, Bahceciler NN, Barlan IB, Müjdat Basaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann. Allergy Asthma Immunol.86, 318–322 (2001).
  • Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin. Pediatr. (Phila.)40, 79–86 (2001).
  • McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst. Rev.2, CD001107 (2000).
  • Scarfone RJ, Loiselle JM, Wiley JF 2nd, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann. Emerg. Med.26, 480–486 (1995).
  • Matthews EE, Curtis PD, McLain BI, Morris LS, Turbitt ML. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta. Paediatr.88, 841–843 (1999).
  • Devidayal Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared with oral prednisolone in acute bronchial asthma. Acta Paediatr.88, 835–840 (1999).
  • Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med.94, 1206–1214 (2000).
  • Milani GK, Rosário Filho NA, Riedi CA, Figueiredo BC. Nebulized budesonide to treat acute asthma in children. J. Pediatr. (Rio J.)80, 106–112 (2004).
  • Songhai S, Banerjee S, Nanjundaswamy H. Inhaled budesonide in acute asthma. J. Paediatr. Child Health35, 483–487 (1999).
  • Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad. Emerg. Med.5, 209–213 (1998).
  • Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst. Rev.3, CD002308 (2003).
  • Schuh S, Reisman J, Alshehri M et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N. Engl. J. Med.343, 689–694 (2000).
  • Schuh S, Dick PT, Stephens D et al. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics118, 644–650 (2006).
  • Daugbjerg P, Brenoe E, Forchhammer H et al. A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr.82, 547–551 (1993).
  • Sano F, Cortez GK, Sole D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J. Allergy Clin. Immunol.105(4), 699–703 (2000).
  • Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J. Allergy Clin. Immunol.101, 464–469 (1998).
  • Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch. Dis. Child.79, 12–17 (1998).
  • Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet363, 271–275 (2004).
  • FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax59, 550–556 (2004).
  • Principi N, Esposito S. Emerging role of Mycoplasma pneumoniaeand Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect. Dis.1, 334–344 (2001).
  • Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J. Antimicrob. Chemother.55, 10–21 (2005).
  • D’Urzo AD. Inhaled glucocorticosteroid and long-acting β2-adrenoceptor agonist single-inhaler combination for both maintenance and rescue therapy: a paradigm shift in asthma management. Treat. Respir. Med.5, 385–391 (2006).
  • Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest130, 1733–1743 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.